FDA clears the way for more consumer genetic health tests to hit the market
The floodgates for direct-to-consumer genetic tests are swinging wide open.
The Food and Drug Administration plans on loosening many of the regulations surrounding genetic health risk tests, or GHRs, according to a Monday from Commissioner Scott Gottlieb. It’s a change of course for the agency, which in 2013 put a freeze on direct-to-consumer
